Yıl: 2021 Cilt: 28 Sayı: 7 Sayfa Aralığı: 1355 - 1361 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2020.06.641 İndeks Tarihi: 07-11-2021

Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients

Öz:
Aim: Ependymomas are highly heterogeneous neuroepithelial tumors that occur in all age groups and in all compartments of the central nervous system. Because of the tumor heterogeneity, the current histopathological criteria for grading are insufficient. Therefore, auxiliary prognostic markers that are cost-effective and easy-to-use and may help predict clinical behavior are still needed. Neural Epidermal Growth Factor Like Like-2 (NELL2) and laminin alpha-2 (LAMA2) are two outstanding proteins with prognostic significance in ependymomas. In the present study, we aimed to investigate the correlation of NELL2 and LAMA2 expression with histopathological parameters in patients with ependymomas.Materials and Methods: A total of 64 ependymomas were retrospectively evaluated and representative paraffin blocks were selected. Demographic and histopathological characteristics of the patients were noted. Slides from selected blocks were immunohistochemically stained using NELL2, LAMA2 and Ki67 antibodies. The results were compared with other characteristics of the patients.Results: We found that the histological grades of the ependymomas correlated with age, tumor localization, histological subtype and number of mitosis. NELL2 staining was significantly higher in grade II ependymomas, while LAMA2 staining was significantly higher in grade III ependymomas. Moreover NELL2 and LAMA2 expression was associated only with the histological grade of the tumor. We found the Ki-67 proliferation index to be consistent with increasing histological grade. Conclusions: Our findings show that higher NELL2 expression than LAMA2 expression is associated with low histological grade and probably better prognosis. On the other hand LAMA2 expression is associated with high histological grade and probably poor prognosis.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
  • 1. Villano JL, Parker CK, Dolecek TA. Descriptive epidemiology of ependymal tumours in the united states. Br J Cancer 2013;108:2367-71.
  • 2. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of Tumours of the Central Nervous System. 4th ed.Lyon: IARC 2016;10-3.
  • 3. Vera-Bolanos E, Aldape K, Yuan y, et al. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. NeuroOncol 2015;17: 440-7.
  • 4. Purdry E, Johnston DL, Bartels U, et al. Ependymoma in children under the age of 3 years: a report from the Canadian Pediatric Brain Tumour Consortium. J Neurooncol 117:359-64.
  • 5. Gatta G, Botta L, Rossi S, et al. EUROCARE Working Group. Childhood cancer survival in Europe 1999- 2007: results of EUROCARE-5- a population-based study. Lancet Oncol.2014;15:35-47.
  • 6. McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: a Surveillance, Epidemiology, and End Results study. J Neurosurg 2009;110:725-9.
  • 7. Kim DH, Roh YG, Lee HH, et al. The E2F1 oncogene transcriptionally regulates NELL2 in cancer cells. DNA Cell Biol 2013;32:517-23.
  • 8. Menezes MJ, McClenahan FK, Leiton CV, et al. The extracellularmatrix protein laminin α2 regulates the maturation and function of the blood-brain barrier. J Neurosci 2014;34:15260-80.
  • 9. Thyboll J, Kortesmaa J, Cao R, et al. Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 2002;22:1194 -202.
  • 10. Witt H, Mack SC, Ryzhova M, et al. Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 2011;20:143-57.
  • 11. Nobusawa S, Hirato J, Yokoo H. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review. The Japan Society of Brain Tumor Pathology 2014 ;31:229-33.
  • 12. Schniederjan MJ, Brat DJ. Biopsy Interpretation of the Central Nervous System 2011:110-25.
  • 13. Pajtler KW, Witt H, Sill M, et al. Molecular Classification of Ependimal Tumors across All CNS Compartments, Histological Grades,and Age Groups. Cancer Cell. 2015;27:728-43.
  • 14. Tihan T, Zhou T, Holmes E, et al. The prognostic value of histological grading of posterior fossa ependymomas in children: a Children‘s Oncology Group study and a review of prognostic factors. ModPathol 2008;21: 165-77.
  • 15. Zawrocki A, Iżycka-Świeszewska E, Papierz W, et al. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literatüre review. FoliaNeuropathol 2011;49:94-102.
  • 16. Prayson RA, Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB1 and p53 immunohistochemistry. Mod Pathol Apr 1997;10:304-10.
  • 17. Prayson RA. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diag Pathol 1999;3:11-8.
  • 18. Cage TA, Clark AJ, Aranda D, et al. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. J Neurosurg Pediatr 2013;11:673-81.
  • 19. Nakamura R, Oyama T, Tajiri R, et al. Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma. CancerSci 2015;106:656-64.
  • 20. Maeda K, Matsuhashi S, Tabuchi K, et al. Brain specific humangenes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors. NeurolMedChir (Tokyo) 2001;41;582-8.
  • 21. Jeong JK, Kim HR, Hwang SM, et al. Region- and Neuronal Phenotype specific Expression of NELL2 in the Adult Rat Brain. MolCells 2008;26:186-92.
  • 22. Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn 2000;218:213-34.
  • 23. Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. AnnuRev Cell Dev Biol 2004;20:255- 84.
  • 24. Vitolo D, Ciocci L, Deriu G, et al. Lamini nalpha 2 chain positive vessels and epidermal growth factor in lung neuroendocrine carcinoma. Am J Pathol 2006;168:991-1003.
  • 25. Leonoudakis D, Huang G, Akhavan A, et al. Endocytic trafficking of laminin is controlled by dystroglycanand is disrupted in cancers. J Cell Sci 2014;127:4894-903.
  • 26. Shu C, Wang Y, Yan X, et al. Prognostic and microRNA profle analysis for CD44 positive expression pediatric posterior fossa ependymoma. Clin Transl Oncol 2018;20:1439-47.
  • 27. Araki A, Chocholous M, Gojo J, et al. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathol Commun2016;4:88.
APA gürçay n, önder e, ÜNAL T, Kertmen H, Alper M (2021). Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. , 1355 - 1361. 10.5455/annalsmedres.2020.06.641
Chicago gürçay nesrin,önder evrim,ÜNAL Tuba Dilay KÖKENEK,Kertmen Hayri,Alper Murat Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. (2021): 1355 - 1361. 10.5455/annalsmedres.2020.06.641
MLA gürçay nesrin,önder evrim,ÜNAL Tuba Dilay KÖKENEK,Kertmen Hayri,Alper Murat Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. , 2021, ss.1355 - 1361. 10.5455/annalsmedres.2020.06.641
AMA gürçay n,önder e,ÜNAL T,Kertmen H,Alper M Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. . 2021; 1355 - 1361. 10.5455/annalsmedres.2020.06.641
Vancouver gürçay n,önder e,ÜNAL T,Kertmen H,Alper M Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. . 2021; 1355 - 1361. 10.5455/annalsmedres.2020.06.641
IEEE gürçay n,önder e,ÜNAL T,Kertmen H,Alper M "Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients." , ss.1355 - 1361, 2021. 10.5455/annalsmedres.2020.06.641
ISNAD gürçay, nesrin vd. "Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients". (2021), 1355-1361. https://doi.org/10.5455/annalsmedres.2020.06.641
APA gürçay n, önder e, ÜNAL T, Kertmen H, Alper M (2021). Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. Annals of Medical Research, 28(7), 1355 - 1361. 10.5455/annalsmedres.2020.06.641
Chicago gürçay nesrin,önder evrim,ÜNAL Tuba Dilay KÖKENEK,Kertmen Hayri,Alper Murat Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. Annals of Medical Research 28, no.7 (2021): 1355 - 1361. 10.5455/annalsmedres.2020.06.641
MLA gürçay nesrin,önder evrim,ÜNAL Tuba Dilay KÖKENEK,Kertmen Hayri,Alper Murat Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. Annals of Medical Research, vol.28, no.7, 2021, ss.1355 - 1361. 10.5455/annalsmedres.2020.06.641
AMA gürçay n,önder e,ÜNAL T,Kertmen H,Alper M Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. Annals of Medical Research. 2021; 28(7): 1355 - 1361. 10.5455/annalsmedres.2020.06.641
Vancouver gürçay n,önder e,ÜNAL T,Kertmen H,Alper M Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients. Annals of Medical Research. 2021; 28(7): 1355 - 1361. 10.5455/annalsmedres.2020.06.641
IEEE gürçay n,önder e,ÜNAL T,Kertmen H,Alper M "Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients." Annals of Medical Research, 28, ss.1355 - 1361, 2021. 10.5455/annalsmedres.2020.06.641
ISNAD gürçay, nesrin vd. "Role of NELL2 and LAMA2 immunohistochemistry in thehistological classification of ependymomas in adult andpediatric patients". Annals of Medical Research 28/7 (2021), 1355-1361. https://doi.org/10.5455/annalsmedres.2020.06.641